A RARE CASE OF METHOTREXATE INDUCED ULCERATED PSORIATIC PLAQUES IN A PATIENT OF PSORIASIS

Girish Joseph, Dinesh K Badyal

Abstract


Methotrexate is an FDA approved drug for treating severe psoriasis. It is associated with toxicity owing to its narrow therapeutic range. Here the patient inappropriately self-administered 40 mg of methotrexate. Following this the patient developed oral mucositis and ulceration within psoriatic plaques. A diagnosis of methotrexate toxicity was made based on clinical findings. The hematological profile was within normal limits. The incidence of ulceration within psoriatic plaques with normal laboratory parameters has been reported very rarely. We report a case where methotrexate toxicity was responsible for ulceration of psoriatic plaques.

 


Keywords


Methotrexate, ulcerated psoriatic plaques, psoriasis.

Full Text:

PDF

References


Bishnoi P, Kumari R, Thappa DM. Monitoring methotrexate hepatotoxicity in psoriasis. Ind J Dermat, Venereology, and Leprology. 2011;77(5):545-8.

Jindal N, Arora K, Jindal P, Jain VK, Ghosh S. Inflamed psoriatic plaques: Drug toxicity or disease exacerbation. Ind J pharmac. 2013;45(4):410-1.

Silva MF, Ribeiro C, Gonçalves VM, Tiritan ME, Lima Á. Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review. Biomedical Chromatography. 2018;32(5).

Madke B, Singh AL. Acute methotrexate toxicity. Ind J of Drugs in Dermat. 2015 ;1(1):46-9.

Menting SP, Dekker PM, Limpens J, Hooft L, Spuls PI. Methotrexate dosing regimen for plaque-type psoriasis: a systematic review of the use of test-dose, start-dose, dosing scheme, dose adjustments, maximum dose and folic acid supplementation. Acta dermato-venereologica. 2016;96(1):23-9.

Agarwal KK, Nath AK, Thappa DM. Methotrexate toxicity presenting as ulceration of psoriatic plaques: a report of two cases. Ind J Dermat, Venereology, and Leprology. 2008;74(5):481-4.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-45.

Edwards IR, Arsonson JK. Adverse drug reactions: Definitions, diagnosis and management. Lancet 2000; 356:1255-9.

Srinivasan R, Ramya G. Adverse drug reaction-causality assessment. Int J Res Pharm Chem. 2011;1(3):606-12.

Bhatnagar A, Verma R, Vasudevan B, Saraswat N. Acute methotrexate toxicity presenting as ulcers in plaques of psoriasis vulgaris. Ind dermat online journal. 2015;6(3):232-3.

Demir FT, Tezcan Y, Türkoğlu Z, Başaran Ş. A case of Severe Low-dose Methotrexate-induced Toxicity. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI. 2016;54(4):252-4.

Fridlington JL, Tripple JW, Reichenberg JS, Hall CS, Diven DG. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue. Dermat online J. 2011;17(11).


Refbacks

  • There are currently no refbacks.